Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

About Hepalink

Established in 1998 in Shenzhen, China, Hepalink is a leading multinational biopharmaceutical company dual-listed in Hong Kong and mainland China. Driven by patient’s unmet needs, Hepalink is striving to fulfill its mission of bringing safe and effective therapies and services to patients around the world.

1998

years

Established in 1998 in Shenzhen

a+h

stocks

Dual-listed in Hong Kong and mainland China

40+

countries and regions

With presence and business operations in over 40 countries and regions around the world

Learn more

Hepalink’s three main business segments

Covering heparin industrial chain, CDMO services of large molecule biologic products, and the research, development, and commercialization of innovative drugs.